ANIMALCARE Group, which develops generic veterinary medicines, has launched two new products.

Sedastart and Sedastop, which are respectively a sedative solution administered to dogs and cats by injection before a general anaesthetic or minor procedures and then an injection after the procedure to reverse the sedative effects, have received approval from the Veterinary Medicines Directorate and the Irish Medicines Board.

The new products, which have a target market turnover of £1 million each, complement Dunnington-based Animalcare’s existing range of analgesia and anaesthesia products to provide a more complete product suite, the business said.

Stephen Wildridge, chief executive, said: “We are very pleased to be able to add Sedastart and Sedastop to our range of analgesics and anaesthetics, an area of strength for our business. Animalcare continues to actively look at new products to add to its range in order to offer its customers a greater range of effective therapies at competitive prices and we expect to launch at least two more new products before the end of 2011.”